For the Inventor, By the Inventor

Enter assignee name

Princeton, NJ, United States of America

Soligenix, Inc.

USPTO Granted Patents = 15

% Expired Patents = 13.3

CIPO Patents = 4

EPO Patents = 12

Trademarks = 4

Forward Citations = 16

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Oreola Donini (7 out of 8 patents)

Annett Rozek (5 out of 16 patents)

Jackson Lee (3 out of 3 patents)

4. John North (3 out of 3 patents)

5. Christopher Schaber (3 out of 3 patents)

6. George McDonald (3 out of 3 patents)

7. Michael J Abrams (3 out of 32 patents)

8. Rasappa Gounder Arumugham (2 out of 12 patents)

9. Holger Rauter (2 out of 8 patents)

10. Silvia Werner (2 out of 6 patents)

11. Shannon Wayne Lentz (2 out of 3 patents)

12. Axel Thomas Lehrer (2 out of 3 patents)

13. Robert N Brey (2 out of 3 patents)

14. Theodore W Randolph (1 out of 34 patents)

15. Panayiotis P Constantinides (1 out of 24 patents)

15 patents: Sort by Forward Citations

1. 12097291 - Thermostable vaccine compositions and methods of preparing same (2024-09-24),

2. 11771757 - Compositions and methods of manufacturing trivalent filovirus vaccines (2023-10-03),

3. 11433129 - Compositions and methods of manufacturing trivalent filovirus vaccines (2022-09-06),

4. 11311598 - Peptides and analogs for use in the treatment of oral mucositis (2022-04-26),

5. 10526268 - Systems and methods for producing synthetic hypericin (2020-01-07),

6. 10293041 - Multivalent stable vaccine composition and methods of making same (2019-05-21),

7. 10253068 - Peptides and analogs for use in the treatment of oral mucositis (2019-04-09),

8. 10053413 - Systems and methods for producing synthetic hypericin (2018-08-21),

9. 9850279 - Peptides and analogs for use in the treatment of oral mucositis (2017-12-26),

10. 9763963 - Topically active steroids for use in interstitial pulmonary fibrosis (2017-09-19),

11. 9416157 - Peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity (2016-08-16),

12. 9168263 - Topically active steroids for use in interstitial pulmonary fibrosis (2015-10-27),

13. 8791061 - Peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity (2014-07-29),

14. 8535650 - Stabilized reverse micelle compositions and uses thereof (2013-09-17),

15. 8263582 - Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids (2012-09-11),

Soligenix, Inc. is a biopharmaceutical company based in Princeton, NJ, specializing in the development of innovative therapeutics for rare diseases and biodefense. The company focuses on advancing its proprietary technologies in areas such as drug development and vaccine formulation. Soligenix's research emphasizes the treatment of conditions related to inflammation, oncology, and infectious diseases, leveraging its expertise to address unmet medical needs and enhance patient outcomes.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Soligenix, Inc.

15 Patents

#62 in Princeton, NJ

#801 in New Jersey

#21,026 in US

#39,846 in the World

Princeton, NJ, United States of America

Soligenix, Inc.

Forward Citations = 16

21 inventors:

Oreola Donini (7 out of 8 patents)

Annett Rozek (5 out of 16 patents)

Jackson Lee (3 out of 3 patents)

4. John North (3 out of 3 patents)

5. Christopher Schaber (3 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…